Heavy intake of refined grains (white bread etc.) is associated in the largest population studies with higher mortality and major cardiovascular disease (archive: PURE, +27% mortality, +33% major cardiovascular events at >=350 g/day).
Original statement
ترتبط كثرة تناوله بارتفاع خطر الوفاة وأمراض القلب والسكري والكبد الدهني والسمنة في أضخم الدراسات السكانية.
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Heavy intake of refined grains (white bread etc.) is associated in the largest population studies with higher mortality and major cardiovascular disease (archive: PURE, +27% mortality, +33% major cardiovascular events at >=350 g/day).
Origin
- Source status
- Archive editors
- Attribution
- Archive editors (study selection and narrative)
- Origin
- https://eltayebat.com/rule/refined-wheat/
- Attribution uncertainty
- Written by the archive operators; the study citations are the archive's, not shown to be Elawady's own.
- Claimed mechanism
Not specified by the archive for this sub-claim (narrative implies the glue mechanism).
- Claimed health effect
Higher all-cause mortality and major cardiovascular events.
- Population concerned
General adult population.
- Geographic restriction by Elawady
none found
Scientific assessment
Potentially true – Some evidence points in favour of the statement, but it is not sufficient for a clear judgement.
Certainty of evidence: low – Further research is likely to change the assessment considerably.
1. What was claimed?
High refined-grain intake raises mortality and heart disease risk, supported by the largest studies.
2. What is demonstrably correct?
In PURE, the highest refined-grain category (>=350 g/day) had HR 1.27 (95% CI 1.11-1.46) for mortality and HR 1.33 (1.16-1.52) for major CVD versus <50 g/day. White bread was associated with mortality per 200 kcal (HR 1.05, 1.03-1.07) while whole-wheat bread was not (1.01, 0.98-1.03) (A-WHT-01, full text).
3. What is wrong or exaggerated?
The archive calls PURE a 'massive meta-analysis'; it is one cohort. The risk was seen at very high intakes, not for moderate intake. The archive's AR headline adds 'raises systolic blood pressure', which PURE reports as an association only. The archive does not mention that A-WHT-02 (its own citation) and other meta-analyses found no clear association for refined grains, nor that PURE found no association for white rice, which the system allows without limit.
4. What remains unclear?
Whether refined grains themselves or the foods and lifestyle that accompany them explain the association; dose-threshold; relevance for Egypt.
5. Which studies support it?
A-WHT-01 (PURE).
6. Which studies contradict it?
A-WHT-02 (little association for refined grains), I-WHT-02 (meta-analysis: refined grains not associated with CVD; author has grain-industry links), I-WHT-108 (dose-response meta-analysis: refined grains not associated with CVD outcomes, low-quality evidence), I-WHT-109 (umbrella review: no clear association with mortality).
7. What applies to Germany and Europe?
The German Nutrition Society and most guidelines recommend preferring whole-grain products; this is based mostly on benefits of whole grain, not proof of harm from moderate refined grain intake.
8. What is known about Egypt?
Bread is a main staple in Egypt (subsidised baladi bread). Very high intakes may be common in some groups, but no Egypt-specific outcome data were identified.
9. What practical conclusion is appropriate?
Very high refined-grain intake may be linked to higher risk; replacing part of it with whole grains is a reasonable, evidence-based step. Moderate intake has not been shown to be harmful.
Assessment details
- Rationale for certainty of evidence
PURE (A-WHT-01) found higher risk only in the extreme category (>=350 g/day, roughly three times the cohort median of 116 g/day) versus <50 g/day. Earlier meta-analyses found little or no association of refined grains with mortality or CVD (A-WHT-02; I-WHT-02 with industry-linked author). Observational data with residual confounding (refined grains often co-occur with sweets and a Western pattern); inconsistent across studies.
- Source quality
A-WHT-01 is a large multinational prospective cohort with good methods; the archive mislabels it as a 'meta-analysis'. A-WHT-02 (cited by the archive) itself reports 'little evidence of an association with refined grains'.
- Regional transferability
PURE included a Middle East region; Egypt-specific data were not identified. Egyptian bread consumption is high, so the upper-intake finding may be relevant.
- Individual exceptions
Not applicable.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
True only under certain conditions – The claim holds only for certain doses, groups of people, preparations or circumstances.
Research question: Is heavy refined-grain intake associated with higher all-cause mortality and major cardiovascular disease in large population studies?
Research question in detail (PECO)
- Population
- General adult population (multinational; Middle East checked)
- Intervention or exposure
- High refined grain intake (e.g. >=350 g/day in PURE)
- Comparison
- Low intake
- Geographic scope
- universal; intake levels region-dependent
- Outcomes
- All-cause mortality
- Major CVD
- CHD
- Stroke
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Very high refined-grain intake and death/heart disease in 21 countries
Swaminathan S et al.. BMJ 2021 · PMID 33536317 · DOI 10.1136/bmj.m4948 Cohort studyfull text checkedPURE (21 countries): the highest refined-grain category was associated with higher mortality and major CVD; the archive reproduces these numbers correctly.
- Actual result
- >=350 vs <50 g/day: mortality HR 1.27 (1.11-1.46); major CVD 1.33 (1.16-1.52).
- Methodological quality
- high (large multinational cohort)
- Relevance
- direct
- Limitations
- Extreme category (3x the median); observational.
Iranian study links refined grains to heart disease, with a reporting problem
Tabesh F et al.. Nutr Metab Cardiovasc Dis 2025 · PMID 39986935 · DOI 10.1016/j.numecd.2025.103866 Case-control studyabstract checkednewly addedIranian case-control study: refined grain foods associated with premature CAD.
- Actual result
- OR 1.43 (0.91-1.84) reported with P=0.013 - internally inconsistent.
- Methodological quality
- low (case-control, reporting error)
- Relevance
- direct, regional
- Limitations
- Recall bias; inconsistent statistics.
What speaks against the claim?
Whole grains linked to lower heart risk; refined grains mostly neutral
Hu H et al.. Am J Clin Nutr 2023 · PMID 36789934 · DOI 10.1016/j.ajcnut.2022.10.010 Meta-analysisabstract checkednewly addedDose-response meta-analysis of 22 refined-grain studies: no significant association with stroke, CHD, heart failure or CVD; mortality signal only in spline; low-quality evidence.
- Actual result
- Refined grains: null for CVD outcomes; NutriGrade low.
- Methodological quality
- moderate (meta-analysis of cohorts)
- Relevance
- direct
- Limitations
- Overlaps with A-WHT-02.
Across many reviews, refined grains were not clearly linked to death risk
Onni AT et al.. Adv Nutr 2025 · PMID 39956388 · DOI 10.1016/j.advnut.2025.100393 Systematic reviewabstract checkednewly addedUmbrella review of 41 meta-analyses: refined grains not clearly associated with mortality.
- Actual result
- Qualitative: no clear association.
- Methodological quality
- high (registered umbrella review)
- Relevance
- direct
- Limitations
- Overlapping meta-analyses.
Refined grains and heart disease (industry-linked author)
Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002 Meta-analysisabstract checkedMeta-analysis: refined grains not significantly associated with CVD.
- Actual result
- CVD HR 1.08 (0.99-1.18; I2 70%).
- Methodological quality
- moderate (author with grain-industry links)
- Relevance
- direct
- Limitations
- COI.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
The PURE finding is real and correctly reproduced, but it concerns very high intakes; across meta-analyses refined grains are not consistently associated with CVD or mortality.
Why some studies weigh more
Meta-analyses and an umbrella review summarise many cohorts but overlap and are mostly from high-income countries; PURE adds diverse low/middle-income data with high intakes.
Is a causal relationship established? Possible, not established Associations limited to extreme intakes and inconsistent; residual confounding by Western dietary pattern likely.
Remaining uncertainty
Whether very high refined-grain intakes typical in some low/middle-income countries (including Egypt) carry risk.
Justified conclusion
Heavy refined-grain intake may carry some risk; moderate intake has not been shown to be harmful.
Why do studies seem to disagree?
PURE (A-WHT-01) vs meta-analyses (I-WHT-108, I-WHT-109, I-WHT-02): different intake ranges (PURE top category >=350 g/day, about 3x its median), different populations (low/middle-income countries) and adjustment sets. They answer different questions rather than truly disagreeing.
Does this depend on the country?
- General biological effects
- Universal.
- Eating habits
- Egyptian baladi bread intake can be very high, so the PURE high-intake category may be relevant.
- Origin of the food
- Not relevant.
- Contaminants
- Not relevant.
- National production conditions
- Subsidised bread in Egypt.
- Legal rules
- Not relevant.
- Actual monitoring data
- No Egyptian outcome data.
A regional difference that changes the conclusion is not supported by robust data.
Statistical re-check
- CI symmetry; extreme category relative to median – HR 1.27 (1.11-1.46) and 1.33 (1.16-1.52) consistent; top category = 3.0x median intake. recalculated
- Internal consistency of OR, CI and P – OR 1.43 not centred in 0.91-1.84 (geometric centre 1.29); CI including 1 conflicts with P=0.013; implied P about 0.05. Reported result unreliable. recalculated
- CI symmetry – Per 30 g whole-grain RRs consistent. recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- All-cause mortality and CVD with high refined-grain intake
- Starting level
- low (observational studies)
- Reasons for downgrading
- inconsistency
- Result
- very low
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- American Heart Association: 2021 Dietary Guidance to Improve Cardiovascular Health (Lichtenstein et al., Circulation 2021) (2021) · Original publication
Abstract: choose whole grain foods and products; choose minimally processed foods instead of ultra-processed foods; minimise added sugars. - WHO: Healthy diet - fact sheet (current version (accessed 2026-10-26)) · Original publication
Carbohydrates should come primarily from whole grains, vegetables, fruits and pulses; examples of whole grains include unprocessed maize, millet, oats, wheat and brown rice.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| PubMed | 26 October 2026 | (refined grain*[tiab] OR white bread[tiab] OR refined cereal*[tiab]) AND (mortality[tiab] OR cardiovascular[tiab] OR coronary[tiab]) AND (meta-analysis[pt] OR systematic review[pt]) AND 2019:2026[dp] | supporting evidence | 19 | |
| Europe PMC | 26 October 2026 | TITLE:("refined grain" OR "refined grains" OR "white bread") AND TITLE:(mortality OR cardiovascular OR "coronary") | both directions | 10 | |
| PubMed | 26 October 2026 | (refined grain*[tiab] OR white bread[tiab] OR bread[ti]) AND (Iran*[tiab] OR Egypt*[tiab] OR Arab*[tiab] OR Middle East*[tiab] OR Tehran[tiab]) AND (cohort[tiab] OR prospective[tiab]) AND (mortality[tiab] OR cardiovascular[tiab] OR diabetes[tiab] OR metabolic syndrome[tiab]) | both directions | 13 | |
| PubMed | 26 October 2026 | Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality[ti] | supporting evidence | 4 |
Open questions
Prospective data from Egypt or the Middle East on high bread intake.
How deeply was this checked?
7 linked studies: 2 checked in full text (1 of them with a structured risk-of-bias assessment), 5 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: Potentially true (low)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Potentially true (low)
Verdict and certainty unchanged. New meta-analyses (I-WHT-108, I-WHT-109) confirm the inconsistency; the archive deserves credit for correct reproduction of PURE. GRADE for the body of evidence is very low, but the specific statement about PURE is accurate, so overall certainty stays low.
New sources: I-WHT-108 I-WHT-109 I-WHT-124
In plain language
One very large study in 21 countries (PURE) found that people eating very large amounts of refined grains, about seven portions a day, died more often and had more heart attacks and strokes than people eating very little. Other large reviews did not find a clear link for normal amounts. Such studies show associations, not proof of cause. Choosing whole-grain bread more often is sensible.
Studies on this claim
Studies supporting the claim (1)
-
Very high refined-grain intake and death/heart disease in 21 countries
Swaminathan S et al.. BMJ 2021 · PMID 33536317 · DOI 10.1136/bmj.m4948Cohort studycited by the Tayebat archivefull text checked★ key studyPeople eating about 7 portions/day of refined grains had 27% higher mortality and 33% more major heart events than those eating very little.
Association at >=350 g/day.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Link grain types to death and heart disease worldwide
- How was the study done?
Followed 137,130 adults for about 9.5 years after a food questionnaire
- How many people, animals or samples were studied?
Adults 35-70 years in 21 countries
- What was actually found?
Very high refined grain intake linked to more deaths and heart events; whole grains and white rice not linked
- How large was the observed effect?
HR 1.27 mortality; HR 1.33 major CVD (top vs bottom category)
- What do the results mean in everyday life?
Eating very large amounts of refined-flour foods may be linked to worse heart health; moderate amounts were not studied as harmful
- What are the study's limitations?
Observational; diet measured once; confounding possible
- What does it say about Elawady's specific claim?
Supports a link at high intakes; does not support the 'glue' mechanism
- Do the results apply to Germany and Europe?
Moderately applicable
- What can explicitly not be concluded from this study?
Cannot show that white flour causes heart disease or that moderate intake is harmful
No study in this group is marked as key.
Studies contradicting or limiting the claim (4)
-
Whole grains and lower risk of heart disease and death
Aune D et al.. BMJ 2016 · PMID 27301975 · DOI 10.1136/bmj.i2716Meta-analysiscited by the Tayebat archivefull text, structured risk-of-bias assessment★ key studyEach 3 servings/day of whole grains linked to 17% lower mortality and 19% lower CHD.
Little association for refined grains.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Summarise studies on whole grains and disease
- How was the study done?
Dose-response meta-analysis
- How many people, animals or samples were studied?
45 cohort studies; up to about 705,000 participants and 100,726 deaths (all-cause mortality analysis).
- What was actually found?
Whole grains linked to less disease; refined grains neutral
- How large was the observed effect?
RR 0.83 mortality per 90 g/day
- What do the results mean in everyday life?
Choosing whole grains is linked to better health
- What are the study's limitations?
Observational data; high heterogeneity for total mortality; no registered protocol; substitution not studied.
- What does it say about Elawady's specific claim?
Supports whole-grain preference, not 'white flour is poison'
- Do the results apply to Germany and Europe?
Applicable
- What can explicitly not be concluded from this study?
Cannot prove cause, cannot quantify the effect of swapping refined for whole grains, and shows no harm from refined grains.
-
Refined grains and heart disease (industry-linked author)
Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002Meta-analysisindependent cross-checkabstract checkedPooled cohorts showed no clear link between refined grains and heart disease.
COI concern.
Does the study support the specific claim? No · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Refined grains and CVD
- How was the study done?
Meta-analysis
- How many people, animals or samples were studied?
17 cohorts
- What was actually found?
No association
- How large was the observed effect?
HR 1.08 (ns)
- What do the results mean in everyday life?
Moderate refined grains not clearly harmful
- What are the study's limitations?
COI, heterogeneity
- What does it say about Elawady's specific claim?
Limits harm claim
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Benefit of refined grains
-
Whole grains linked to lower heart risk; refined grains mostly neutral
Hu H et al.. Am J Clin Nutr 2023 · PMID 36789934 · DOI 10.1016/j.ajcnut.2022.10.010Meta-analysisindependent cross-checkabstract checked★ key studyIn 1.6 million people, each 30 g/day of whole grains was linked to 6-8% lower CVD and death risk; refined grains showed no clear link with heart disease.
Refined grains not associated with CVD outcomes; mortality signal only in spline, low-quality evidence.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Summarise grain intake and CVD/death.
- How was the study done?
Meta-analysis of cohorts.
- How many people, animals or samples were studied?
1,624,407 participants.
- What was actually found?
Whole grains protective; refined mostly null.
- How large was the observed effect?
Mortality RR 0.94 per 30 g whole grain.
- What do the results mean in everyday life?
Choose whole grains; moderate white bread not shown harmful.
- What are the study's limitations?
Observational.
- What does it say about Elawady's specific claim?
Supports whole-grain claim; weakens refined-harm claim.
- Do the results apply to Germany and Europe?
Moderate-high.
- What can explicitly not be concluded from this study?
Cannot prove causation.
-
Across many reviews, refined grains were not clearly linked to death risk
Onni AT et al.. Adv Nutr 2025 · PMID 39956388 · DOI 10.1016/j.advnut.2025.100393Systematic reviewindependent cross-checkabstract checkedAn umbrella review of 41 meta-analyses found lower mortality with whole grains but no clear association for refined grains.
Refined grains not clearly associated with mortality across meta-analyses.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Summarise food groups and mortality.
- How was the study done?
Umbrella review.
- How many people, animals or samples were studied?
41 meta-analyses.
- What was actually found?
Whole grains beneficial; refined neutral.
- How large was the observed effect?
Not quantified in abstract.
- What do the results mean in everyday life?
Whole grains are the better choice; white bread not proven deadly.
- What are the study's limitations?
Overlap.
- What does it say about Elawady's specific claim?
Weakens the refined-harm claim.
- Do the results apply to Germany and Europe?
Moderate-high.
- What can explicitly not be concluded from this study?
Cannot prove causation.
No study in this group is marked as key.
Studies with mixed or unclear results (2)
-
Fibre and whole grains and health
Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9Meta-analysisindependent cross-checkabstract checked★ key studyHigh fibre/whole grain intake linked to 15-30% lower risk of several diseases; GI/GL evidence weaker.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Carbohydrate quality
- How was the study done?
Systematic reviews with GRADE
- How many people, animals or samples were studied?
185 cohorts, 58 trials
- What was actually found?
Fibre and whole grain protective
- How large was the observed effect?
15-30% lower risk
- What do the results mean in everyday life?
Eat more fibre and whole grains
- What are the study's limitations?
Observational core
- What does it say about Elawady's specific claim?
Supports whole grains, not glue mechanism; GI/GL arguments weak
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Harm from moderate refined grains
-
Iranian study links refined grains to heart disease, with a reporting problem
Tabesh F et al.. Nutr Metab Cardiovasc Dis 2025 · PMID 39986935 · DOI 10.1016/j.numecd.2025.103866Case-control studyindependent cross-checkabstract checkedIn an Iranian case-control study, whole grains were linked to 46% lower odds of coronary disease; the refined-grain result (OR 1.43) is reported with a confidence interval that includes no effect.
Direction supports the claim, but case-control design and an internally inconsistent OR/CI.
Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Grains and coronary disease in Iran.
- How was the study done?
Case-control study.
- How many people, animals or samples were studied?
3267 adults.
- What was actually found?
Whole grains protective; refined grains possibly harmful.
- How large was the observed effect?
OR 0.54 and 1.43.
- What do the results mean in everyday life?
Consistent direction with Western data for whole grains.
- What are the study's limitations?
Recall bias; inconsistent statistics.
- What does it say about Elawady's specific claim?
Weak support for the refined-grain claim.
- Do the results apply to Germany and Europe?
Low-moderate.
- What can explicitly not be concluded from this study?
Cannot establish that refined grains cause CAD.
No study in this group is marked as key.
Regional context
Germany / EU
The German Nutrition Society and most guidelines recommend preferring whole-grain products; this is based mostly on benefits of whole grain, not proof of harm from moderate refined grain intake.
Egypt
Bread is a main staple in Egypt (subsidised baladi bread). Very high intakes may be common in some groups, but no Egypt-specific outcome data were identified.
What applies in my country?
General scientific assessment
Potentially true A link with harm exists at very high intakes in one major cohort, but the overall evidence is inconsistent and does not show that moderate white-bread intake is dangerous.
The following areas of food safety are relevant to this statement:
- Pesticides and pesticide residues
- Contaminants (heavy metals, PFAS, PCBs, dioxins, nitrate)
- Mycotoxins (mould toxins)
Cereals and rice
Choose a country to see the checked information for it.
Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.
Country of residence or purchase Compare with another country
References
- Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study.. Swaminathan S et al.. BMJ 2021 · PMID 33536317 · DOI 10.1136/bmj.m4948
- Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.. Aune D et al.. BMJ 2016 · PMID 27301975 · DOI 10.1136/bmj.i2716
- Refined grain intake and cardiovascular disease: Meta-analyses of prospective cohort studies.. Gaesser GA. Trends Cardiovasc Med 2024 · PMID 36075506 · DOI 10.1016/j.tcm.2022.08.002
- Consumption of whole grains and refined grains and associated risk of cardiovascular disease events and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies.. Hu H et al.. Am J Clin Nutr 2023 · PMID 36789934 · DOI 10.1016/j.ajcnut.2022.10.010
- Umbrella Review of Systematic Reviews and Meta-analyses on Consumption of Different Food Groups and Risk of All-cause Mortality.. Onni AT et al.. Adv Nutr 2025 · PMID 39956388 · DOI 10.1016/j.advnut.2025.100393
- Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.. Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9
- Association of whole and refined grains food consumption with coronary artery disease in a multi-center, case-control study of Iranian adults: Iran Premature Coronary Artery Disease (IPAD).. Tabesh F et al.. Nutr Metab Cardiovasc Dis 2025 · PMID 39986935 · DOI 10.1016/j.numecd.2025.103866